EurekAlert! -
1 Apr 2017 06:00
(UNC Lineberger Comprehensive Cancer Center) In preliminary findings that will be presented Sunday, April 2, at the American Association for Cancer Research Annual Meeting 2017, UNC Lineberger researchers report on a preclinical study into the use of nanoparticles to improve the efficacy of immunotherapy drugs known as checkpoint inhibitors.
Share this Article